ClinConnect ClinConnect Logo
Search / Trial NCT04925531

Antibiotic Use in Facial Fracture Post Injury

Launched by METHODIST HEALTH SYSTEM · Jun 7, 2021

Trial Information

Current as of September 08, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the use of antibiotics after surgery for facial fractures, which are injuries that can occur due to accidents or trauma. The researchers want to find out if giving antibiotics for 3 days or 5 days after surgery can help prevent infections better than other treatment methods. Infections can be a common problem after surgery, and while short-term antibiotic use may not be enough, longer use can lead to other issues, such as allergic reactions or drug resistance.

To participate in this trial, you must be at least 18 years old and have suffered a blunt or penetrating injury that resulted in a facial fracture. Unfortunately, pregnant or breastfeeding women are not eligible to join. If you decide to participate, you will receive either a 3-day or 5-day course of antibiotics after your surgery, and researchers will monitor your recovery to see how well this treatment works in preventing infections. This trial is currently recruiting participants and aims to improve care for patients with facial injuries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and female patient's ≥ 18 years of age.
  • Blunt and penetration injury.
  • Exclusion Criteria:
  • Pregnant and breast feeding women.

About Methodist Health System

Methodist Health System is a leading healthcare provider dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific inquiry, the organization leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies across various therapeutic areas. Methodist Health System collaborates with healthcare professionals, researchers, and industry partners to enhance the understanding of diseases and develop new treatment modalities, ensuring that cutting-edge therapies are accessible to the communities it serves. Through its clinical trial initiatives, Methodist Health System aims to contribute to the evolving landscape of medicine while prioritizing patient safety and ethical standards.

Locations

Dallas, Texas, United States

Patients applied

0 patients applied

Trial Officials

Michael Truitt, M.D.

Principal Investigator

The Methodist Hospital Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials